Skip to Content
Merck
CN
  • Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort.

Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort.

Nutrition and cancer (2012-11-10)
Anna K Sczaniecka, Theodore M Brasky, Johanna W Lampe, Ruth E Patterson, Emily White
ABSTRACT

Studies of dietary fat intake and breast cancer have been inconsistent and few have examined specific fatty acids. We examined the association between specific monounsaturated (MUFA), polyunsaturated (PUFA), saturated (SFA), and trans-fatty acids (TFA) and breast cancer risk. Participants, 50-76 yr, were female members of the VITamins And Lifestyle (VITAL) Cohort, who were postmenopausal at baseline. In 2000-2002, participants completed a food frequency questionnaire. Seven hundred seventy-two incident, primary breast cancer cases were identified using a population-based cancer registry. Cox proportional hazard models estimated hazard ratios (HR) and 95% confidence intervals (95% CI) for the association between fatty acid intake and breast cancer risk. Intake of total MUFAs (highest vs. lowest quintile: HR = 1.61, 95% CI: 1.08-2.38, P trend = 0.02), particularly myristoleic and erucic acids, was associated with increased breast cancer risk. Whereas total SFA was suggestive of an increased risk (HR = 1.47, 95% CI: 1.00-2.15, P trend = 0.09), strong associations were observed for palmitic, margaric, and stearic acids. Total TFA and PUFA intake were not associated with breast cancer. However, among TFAs, linolelaidic acid was positively associated with risk; among PUFAs, intake of eicosapentaenoic and docosahexaenoic acids were inversely associated with risk. Our findings show that fatty acids are heterogeneous in their association with postmenopausal breast cancer risk.

MATERIALS
Product Number
Brand
Product Description

Supelco
Erucic acid, analytical standard
Sigma-Aldrich
Erucic acid, technical, ~90% (GC)
Sigma-Aldrich
Erucic acid, ≥99% (capillary GC)
Sigma-Aldrich
Myristoleic acid, ≥99% (capillary GC)